MedPath

Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation

Phase 4
Completed
Conditions
Previous Vka Treatment
Previous Proximal VTE
Registration Number
NCT00860106
Lead Sponsor
University Hospital, Grenoble
Brief Summary

The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation.

The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.

Detailed Description

DDimer levels are centralized in University Hospital of Grenoble at the end of the study

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
222
Inclusion Criteria
  • > 18 and <80 years old
  • First or second treated proximal VTE event (+/- Pulmonary embolism)
  • Signed informed consent
Exclusion Criteria
  • Active cancer or currently treated
  • Previous VTE>2
  • Long term anticoagulant treatment for VTE diseases
  • Long term anticoagulant treatment for other diseases
  • Pregnancy, parturient or breast feeding
  • Person deprived of freedom by judicial or administrative decision
  • Consent unsigned

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
VTE event recurrence0-2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

University Hospital

🇫🇷

Amiens, France

Cabinet Medical

🇫🇷

Voiron, France

HOSPITAL

🇫🇷

Chambery, France

Vascular Medecine Departement - University Hospital of Grenoble

🇫🇷

Grenoble, France

Clinique Mutualiste les eaux claires

🇫🇷

Grenoble, France

CMC Les Petites Roches

🇫🇷

Saint Hilaire Du Touvet, France

University Hospital
🇫🇷Amiens, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.